23448 (LAB.TO) (LAB) Scheduled to Post Quarterly Earnings on Wednesday

23448 (LAB.TO) (TSE:LAB) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, May 15th. Analysts expect 23448 (LAB.TO) to post earnings of C($0.01) per share for the quarter.

23448 (LAB.TO) (TSE:LAB) last posted its quarterly earnings data on Wednesday, March 27th. The company reported C($0.01) EPS for the quarter, hitting the consensus estimate of C($0.01). The firm had revenue of C$9.13 million for the quarter, compared to the consensus estimate of C$8.67 million.

23448 (LAB.TO) Price Performance

About 23448 (LAB.TO)

Fluidigm focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, it develops, manufactures, and markets multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies.